Free Trial
NASDAQ:SINT

Sintx Technologies 3/27/2024 Earnings Report

Sintx Technologies logo
$4.70 -0.23 (-4.67%)
Closing price 03:58 PM Eastern
Extended Trading
$4.70 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sintx Technologies EPS Results

Actual EPS
-$18.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Sintx Technologies Revenue Results

Actual Revenue
$0.90 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Sintx Technologies Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Sintx Technologies' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules.

Conference Call Resources

Sintx Technologies Earnings Headlines

Trump’s Plan May Undo 1933’s Biggest Financial Injustice
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.tc pixel
See More Sintx Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sintx Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sintx Technologies and other key companies, straight to your email.

About Sintx Technologies

Sintx Technologies (NASDAQ:SINT) (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws. Sintx employs proprietary ceramic processing and additive manufacturing techniques to produce high-purity, high-density silicon nitride parts. This advanced material has demonstrated reduced bacterial adhesion, enhanced osteointegration and favorable imaging characteristics under X-ray and CT scanning compared with conventional metallic implants.

Founded in 2006 and headquartered in Salt Lake City, Utah, Sintx Technologies operates research and manufacturing facilities in the United States. The company has built a portfolio of patents covering silicon nitride composition, processing methods and medical device designs, and it collaborates with implant manufacturers, contract research organizations and academic institutions to advance clinical evaluation and regulatory approvals worldwide. Through distribution partnerships and OEM agreements, Sintx serves both domestic and select international markets, supporting early adopters in the spine and trauma segments as well as emerging applications in dental and orthobiologics.

Sintx is led by an executive team with experience in biomaterials, medical device development and regulatory affairs. The company continues to invest in R&D to expand its silicon nitride platform technology, pursuing new indications and commercial alliances that leverage the unique combination of strength, bioactivity and antimicrobial performance inherent in its ceramics.

View Sintx Technologies Profile

More Earnings Resources from MarketBeat